Concepedia

Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis

Carla Rognoni, Monia Marchetti, Silvana Quaglini, Nicola Lucio Liberato

Clinical Drug Investigation · 2013 · 64 citations · 33 references

DOI

Concepts

References

33

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

, , +12

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

, , +15

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text

, , +11

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Philip A. Wolf, Robert D. Abbott, W B Kannel · Stroke · 1991 · 7.5K citations

, , +14

Antithrombotic Therapy for VTE Disease

Clive Kearon, Elie A. Akl, Anthony J. Comerota et al. · CHEST Journal · 2012 · 6.1K citations · Full text

, , +12